Related Experiment Video
Updated: May 3, 2026
05:35
Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
Published on: May 31, 2022
3.3K
Human iPSC-Derived Microglia Integrate Into Cerebral Organoids and Assume an In Vivo-Like Phenotype
Emile Wogram1,2, Felix Sümpelmann1, Andrew Khalil1,3,4
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
The European Journal of Neuroscience
|November 12, 2025
Summary
Researchers developed a novel cerebral organoid platform to study human microglia, the brain's immune cells. This method overcomes limitations of traditional cell cultures and mouse models for better disease research and drug discovery.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are crucial brain immune cells involved in neurological diseases.
- Current in vitro and in vivo models have significant limitations for studying human microglia.
Purpose of the Study:
- To develop a controlled in vitro platform for studying human microglia.
- To enable in vivo-like microglial phenotype for disease modeling and drug testing.
Main Methods:
- Developed a highly controlled in vitro cerebral organoid platform.
- Cultured human microglia within the organoid system.
Main Results:
- Human microglia in the organoid platform adopted an in vivo-like phenotype.
- The platform supports long-term studies and high-throughput analysis.
Conclusions:
- The cerebral organoid platform provides a robust model for human microglia research.
- This approach facilitates advancements in neurological disease modeling and therapeutic development.
